Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Global Health Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹1,380.00
High
₹1,446.70
Price Summary
| Previous Close | ₹1,393.50 |
|---|---|
| Day's Range | ₹1,380.00 - ₹1,446.70 |
| Open | ₹1,440.40 |
| 52 Week Range | ₹956.00 - ₹1,491.00 |
| Volume | 2,43,269 |
| Market Cap | ₹0.04 |
| Previous Close | ₹1,394.95 |
|---|---|
| Day's Range | ₹1,383.45 - ₹1,447.15 |
| Open | ₹1,437.30 |
| 52 Week Range | ₹955.20 - ₹1,490.00 |
| Volume | 8,170 |
| Market Cap | ₹0.04 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 3,436.73 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 0.04 |
| Price/Earning (TTM) | 67.44 |
| TTM EPS (₹) | 20.69 |
| P/E Ratio | 66.85 |
| Book Value(₹) | 9.09 |
| PAT Margin (%) | 13.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 20.50 |
| Trade Value ( ₹ in Lacs) | 115.00 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 0.04 |
| Price/Earning (TTM) | 67.44 |
| TTM EPS (₹) | 20.69 |
| P/E Ratio | 66.85 |
| Book Value(₹) | 9.09 |
| PAT Margin (%) | 13.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 20.50 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 10308.44 | 32041.46 |
| Expenses | N/A | N/A |
| PBT | 2081.41 | 6230.47 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1589.82 | 4615.28 |
About Global Health Ltd.
| Founded | 2004 |
|---|---|
| Managing Director | Naresh Trehan |
| NSE Symbol | MEDANTA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,64,271.32 | 1,935.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,26,842.90 | 8,545.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,999.88 | 4,890.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,23,151.56 | 8,565.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,20,099.46 | 1,204.00 | 835.50 - 835.50 |
| Cipla Ltd. | 1,18,071.78 | 1,461.55 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,03,549.99 | 2,264.70 | 1,875.00 - 1,875.00 |
| Lenskart Solutions Ltd. | 1,02,019.00 | 587.00 | 0.00 - 0.00 |
| Mankind Pharma Ltd. | 1,00,137.07 | 2,424.65 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,00,073.46 | 1,198.95 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Jun
18
2026
Posted on Jun 18th 2026
Global Health informs about analyst meet
Global Health has informed that the Company’s Management will meet Investors/Analysts in Meetings organised by Nuvama Institutional Equities as on June 24, 2026, June 25, 2026 and June 26, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
13
2026
Posted on Aug 13th 2026
Caplin Point Labs. - Quaterly Results
The June 2026 quarter revenue stood at Rs. 2029.50 millions, up 11.16% as compared to Rs. 1825.70 millions during the corresponding quarter last year.Good Net Profit growth of 40.16% reported above the corresponding previous quarter figure of Rs. 858.90 millions to Rs. 1203.80 millioins.Operating profit surged to 1572.00 millions from the corresponding previous quarter of 1186.40 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 2029.50 | 1825.70 | 11.16 | 2029.50 | 1825.70 | 11.16 | 7383.30 | 7524.10 | -1.87 |
| Other Income | 627.90 | 320.30 | 96.03 | 627.90 | 320.30 | 96.03 | 1953.70 | 1345.90 | 45.16 |
| PBIDT | 1572.00 | 1186.40 | 32.50 | 1572.00 | 1186.40 | 32.50 | 5331.50 | 4665.60 | 14.27 |
| Interest | 0.50 | 0.40 | 25.00 | 0.50 | 0.40 | 25.00 | 2.00 | 1.20 | 66.67 |
| PBDT | 1571.50 | 1186.00 | 32.50 | 1571.50 | 1186.00 | 32.50 | 5329.50 | 4664.40 | 14.26 |
| Depreciation | 65.60 | 61.40 | 6.84 | 65.60 | 61.40 | 6.84 | 254.30 | 247.70 | 2.66 |
| PBT | 1505.90 | 1124.60 | 33.91 | 1505.90 | 1124.60 | 33.91 | 5075.20 | 4416.70 | 14.91 |
| TAX | 302.10 | 265.70 | 13.70 | 302.10 | 265.70 | 13.70 | 1109.40 | 1021.80 | 8.57 |
| Deferred Tax | 14.50 | -3.40 | -526.47 | 14.50 | -3.40 | -526.47 | 14.50 | -7.20 | -301.39 |
| PAT | 1203.80 | 858.90 | 40.16 | 1203.80 | 858.90 | 40.16 | 3965.80 | 3394.90 | 16.82 |
| Equity | 152.00 | 152.00 | 0.00 | 152.00 | 152.00 | 0.00 | 152.00 | 152.00 | 0.00 |
| PBIDTM(%) | 77.46 | 64.98 | 19.20 | 77.46 | 64.98 | 19.20 | 72.21 | 62.01 | 16.45 |
Read More
Aug
13
2026
Posted on Aug 13th 2026
Kerala Ayurveda - Quaterly Results
The sales for the June 2026 quarter moved up 28.25% to Rs. 225.29 millions as compared to Rs. 175.66 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2026 is Rs. -76.68 millions as compared to Net Profit of Rs. 20.68 millions of corresponding quarter ended June 2025Operating profit Margin for the quarter ended June 2026 slipped to -38.15% as compared to 45.72% of corresponding quarter ended June 2025
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 225.29 | 175.66 | 28.25 | 225.29 | 175.66 | 28.25 | 854.85 | 726.89 | 17.60 |
| Other Income | 12.78 | 99.99 | -87.22 | 12.78 | 99.99 | -87.22 | 179.35 | 51.71 | 246.84 |
| PBIDT | -38.15 | 45.72 | -183.44 | -38.15 | 45.72 | -183.44 | -50.81 | -74.16 | -31.49 |
| Interest | 28.09 | 7.70 | 264.81 | 28.09 | 7.70 | 264.81 | 72.70 | 39.16 | 85.65 |
| PBDT | -66.24 | 38.02 | -274.22 | -66.24 | 38.02 | -274.22 | -123.51 | -113.32 | 8.99 |
| Depreciation | 14.05 | 12.26 | 14.60 | 14.05 | 12.26 | 14.60 | 35.95 | 21.51 | 67.13 |
| PBT | -80.29 | 25.76 | -411.68 | -80.29 | 25.76 | -411.68 | -159.46 | -134.83 | 18.27 |
| TAX | -3.61 | 5.08 | -171.06 | -3.61 | 5.08 | -171.06 | -12.05 | 2.98 | -504.36 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -76.68 | 20.68 | -470.79 | -76.68 | 20.68 | -470.79 | -147.41 | -137.81 | 6.97 |
| Equity | 129.95 | 120.32 | 8.00 | 129.95 | 120.32 | 8.00 | 126.90 | 120.32 | 5.47 |
| PBIDTM(%) | -16.93 | 26.03 | -165.06 | -16.93 | 26.03 | -165.06 | -5.94 | -10.20 | -41.74 |
Read More
Aug
13
2026
Posted on Aug 13th 2026
Shukra Pharmaceut. - Quaterly Results
An increase of about 336.32% to Rs. 235.22 millions in the total revenue was observed for the quarter ended June 2026. The total revenue was pegged at Rs. 53.91 millions during the similar quarter previous year.Net Profit for the quarter ended June 2026 zoomed to 1360.64% from Rs. 10.29 millions to Rs. 150.30 millions.OP of the company witnessed a marginal growth to 217.46 millions from 24.28 millions in the same quarter last year.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 235.22 | 53.91 | 336.32 | 235.22 | 53.91 | 336.32 | 567.06 | 325.87 | 74.01 |
| Other Income | 5.40 | 11.10 | -51.35 | 5.40 | 11.10 | -51.35 | 45.85 | 42.07 | 8.99 |
| PBIDT | 217.46 | 24.28 | 795.63 | 217.46 | 24.28 | 795.63 | 333.09 | 169.36 | 96.68 |
| Interest | 4.30 | 2.68 | 60.45 | 4.30 | 2.68 | 60.45 | 10.93 | 5.95 | 83.70 |
| PBDT | 213.16 | 21.60 | 886.85 | 213.16 | 21.60 | 886.85 | 322.16 | 163.41 | 97.15 |
| Depreciation | 10.74 | 7.87 | 36.47 | 10.74 | 7.87 | 36.47 | 34.43 | 30.05 | 14.58 |
| PBT | 202.42 | 13.73 | 1374.29 | 202.42 | 13.73 | 1374.29 | 287.73 | 133.36 | 115.75 |
| TAX | 52.12 | 3.44 | 1415.12 | 52.12 | 3.44 | 1415.12 | 67.26 | 37.62 | 78.79 |
| Deferred Tax | 0.44 | -0.62 | -170.97 | 0.44 | -0.62 | -170.97 | -22.19 | 1.38 | -1707.97 |
| PAT | 150.30 | 10.29 | 1360.64 | 150.30 | 10.29 | 1360.64 | 220.47 | 95.74 | 130.28 |
| Equity | 437.88 | 437.88 | 0.00 | 437.88 | 437.88 | 0.00 | 437.88 | 437.88 | 0.00 |
| PBIDTM(%) | 92.45 | 45.04 | 105.27 | 92.45 | 45.04 | 105.27 | 58.74 | 51.97 | 13.02 |
Read More
Aug
13
2026
Posted on Aug 13th 2026
Aspira Pathlab&Diagn - Quaterly Results
The June 2026 quarter revenue stood at Rs. 61.69 millions, up 17.55% as compared to Rs. 52.48 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2026 is Rs. -0.38 millions as compared to Net Profit of Rs. 4.70 millions of corresponding quarter ended June 2025A decline of 4.63 millions was observed in the OP in the quarter ended June 2026 from 9.29 millions on QoQ basis.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 61.69 | 52.48 | 17.55 | 61.69 | 52.48 | 17.55 | 249.82 | 219.99 | 13.56 |
| Other Income | 1.20 | 1.08 | 11.11 | 1.20 | 1.08 | 11.11 | 5.16 | 3.89 | 32.65 |
| PBIDT | 4.63 | 9.29 | -50.16 | 4.63 | 9.29 | -50.16 | 19.79 | 39.14 | -49.44 |
| Interest | 0.92 | 0.94 | -2.13 | 0.92 | 0.94 | -2.13 | 3.89 | 3.47 | 12.10 |
| PBDT | 3.71 | 8.35 | -55.57 | 3.71 | 8.35 | -55.57 | 15.90 | 35.67 | -55.42 |
| Depreciation | 4.09 | 3.65 | 12.05 | 4.09 | 3.65 | 12.05 | 15.38 | 14.94 | 2.95 |
| PBT | -0.38 | 4.70 | -108.09 | -0.38 | 4.70 | -108.09 | 0.52 | 20.73 | -97.49 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -0.38 | 4.70 | -108.09 | -0.38 | 4.70 | -108.09 | 0.52 | 20.73 | -97.49 |
| Equity | 102.93 | 102.93 | 0.00 | 102.93 | 102.93 | 0.00 | 102.93 | 102.93 | 0.00 |
| PBIDTM(%) | 7.51 | 17.70 | -57.60 | 7.51 | 17.70 | -57.60 | 7.92 | 17.79 | -55.48 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Global Health Ltd. is ₹1,393.50 as of 2026-08-12.
The market capitalisation of Global Health Ltd. is ₹37,506.27 as of 2026-08-12.
The 1-year return of Global Health Ltd. is 13.20% as of 2026-08-12.
The P/E ratio of Global Health Ltd. is 66.85 as of 2026-08-13.
The 52-week high and low of Global Health Ltd. are ₹1,491.00 and ₹956.00, respectively, as of 2026-08-12.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
